Maike Dohrn, MD

Following her medicine studies at the RWTH Aachen University (2008-2014), Maike F. Dohrn has received a five-year training in general neurology at the University Hospital in Aachen, Germany. Since 2011, she has developed a clinical and scientific focus on rare neuromuscular diseases at the neuromuscular center Aachen, added by research internships at the Center of Genomics and Transcriptomics (CeGaT) in Tübingen, Germany, in 2016 and at the Corino Andrade Unit of the University of Porto, Portugal, in 2017. She has been conducting studies on Charcot-Marie-Tooth disease, hereditary sensory and autonomic neuropathies, transthyretin-related hereditary amyloidosis, small fiber neuropathies, inflammatory neuropathies, and motor neuron diseases, and became an expert in neuromuscular genetics, neurophysiology, and nerve ultrasound. As a co-investigator, she participated in the German CMT registry, the national CMT-NET, the international THAOS registry, and further multicenter trials. In the new Sodium channel network Aachen (SCNAC), she is the principal investigator for the clinical sub-project (Z-project). Despite being one of the youngest researchers in this field, she has already received fundings and scholarships from organizations including IZKF, ASPIRE, and DFG and won several awards (RADIZ rare disease award,  Borchers badge, and Springorium coin) for her work. Currently, she is a research scholar at Professor Stephan Züchner's group at the John P. Hussman Institute for Human Genomics at the University of Miami.